ArticleJAMA network open2021

The Association of Drug-Funding Reimbursement With Survival Outcomes and Use of New Systemic Therapies Among Patients With Advanced Pancreatic Cancer.

Michael J Raphael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.